Similar articles

• European patents. Tough stance on stem cell, DNA claims.

  Vogel G. Vogel G. Science. 2002 Aug 2;297(5582):754-5. doi: 10.1126/science.297.5582.754. Science. 2002. PMID: 12161624 No abstract available.
• Monsters at the patent office: the inconsistent conclusions of moral utility and the controversy of human cloning.

  Smith AR. Smith AR. De Paul Law Rev. 2003 Fall;53(1):159-203. De Paul Law Rev. 2003. PMID: 15568254 No abstract available.
• Lamb chopped: Dolly not patent eligible.

  Harrison C. Harrison C. Nat Rev Drug Discov. 2014 Jun;13(6):408. doi: 10.1038/nrd4353. Nat Rev Drug Discov. 2014. PMID: 24875088 No abstract available.
• The attack of the clones: patent law and stem cell research.

  Rimmer M. Rimmer M. J Law Med. 2003 May;10(4):488-505. J Law Med. 2003. PMID: 12852321 Review.
• Bio-patents, law and ethics. Critical analysis of the EU biotechnology directive.

  Van Overwalle G. Van Overwalle G. Rev Derecho Genoma Hum. 2003 Jul-Dec;(19):187-203. Rev Derecho Genoma Hum. 2003. PMID: 15032104 Review. No abstract available.